Development and assessment of a brief screening tool for psychosis in dementia

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Hallucinations and delusions (H+D) are common in dementia, but screening for these symptoms—especially in busy clinical practices—is challenging. Methods: Six subject matter experts developed the DRP3™ screen, a novel valid tool to detect H+D in dementia, assessed its content validity through alignment with DRP reference assessments (Scale for the Assessment of Positive Symptoms-Hallucinations + Delusions, Neuropsychiatric Inventory-Questionnaire, International Psychogeriatric Association Criteria), and retrospectively investigated its ability to detect H+D in HARMONY trial (NCT03325556) enrollees. Results: All items from three reference assessments demonstrated significant agreement with the DRP3 screen among raters (P

Cite

CITATION STYLE

APA

Cummings, J. L., Ismail, Z., Dickerson, B. C., Ballard, C., Grossberg, G., McEvoy, B., … Atri, A. (2021). Development and assessment of a brief screening tool for psychosis in dementia. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 13(1). https://doi.org/10.1002/dad2.12254

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free